From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Hypertension>
  4. Archives

Hypertension: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 151-175 of 195 are shown

Inadequate Secondary Prevention After Stroke

Secondary prevention efforts are inadequate despite the high risk for secondary cardiovascular events among survivors of either myocardial infarction or stroke.

CCB vs. ACE Inhibitor in High-Risk Hypertension

A new ALLHAT analysis reveals that amlodipine has some outcome advantages over lisinopril.

Antiangiogenic Markers of Preeclampsia

Could measurement of circulating levels of certain antiangiogenic proteins someday identify women at high risk for preeclampsia?

Hypertension in Kidney Donors

This meta-analysis suggests that blood pressure increases after kidney donation.

Involving Patients in Their Own Care Improves BP Control

. . .but the reason for the improvement is not clear.

Can a Hormone Therapy Combat Hypertension?

Promise but caution: Drospirenone reduced blood pressure in postmenopausal women.

Guidelines on Secondary Prevention of Ischemic Stroke

  • Neurology
  • Clinical Practice Guideline Watch
  • Free

Updated guidelines from the American Heart Association and the American Stroke Association

Blood Pressure and the J-Curve Phenomenon

In patients with hypertension and coronary artery disease, a J-curve was evident for the relation between BP and adverse outcomes, but the relation was attenuated after adjustment for baseline factors.

Can an ARB Reduce BP and CRP Levels?

Valsartan reduced C-reactive protein levels, independent of its BP-lowering effect, in a trial that lacked a non-ARB control group.

Treat Hypertension, Prevent Dementia?

An observational study of older men raises the possibility of such a benefit if treatment lasts at least 5 years.

C-Reactive Protein: Not Ready for Population-Wide CVD Risk Assessment

Traditional risk factors alone are still the best predictors of CVD risk.

ACE Inhibitors and Birth Defects: Unsafe in Any Trimester

Treatment with ACE inhibitors increases risk for major malformations when used in the first trimester as well as later in pregnancy.

Which Comes First, Cardiac Risk or Menopause?

Increases in cardiac risk factors are associated with earlier menopause.

Diastolic BP in Patients with CAD: How Low Is Too Low?

Baseline diastolic BP had a J-shaped relation with risks for death and MI among CAD patients treated with antihypertensive drugs in the INVEST trial.

Nighttime BP and Risk for Heart Failure

Nighttime blood pressure as high as, or higher than, daytime BP was associated with increased risk for heart failure.

Another Look at ß-Blockers for Hypertension

ß-blockers might be more acceptable first-line drugs for younger hypertensive patients than for older patients.

Blood Pressure and Mortality in the Very Old

Patients with systolic BP <140 mm Hg had significantly increased all-cause mortality risk.

Ethnicity Affects Reactions to Cardiovascular Drugs

Possible associations between ADRs and ethnicity should be examined in studies of new drugs.

ACE Inhibitors Are Teratogenic in the First Trimester

Specifically, these drugs were associated with increased infant risks for cardiovascular and nervous system anomalies.

Which Antihypertensive Best Prevents HF in Patients with High BP?

ALLHAT data bolster the case for diuretic-based therapy.

Antihypertensive Drugs and Risk for Diabetes

Prospective data from three large cohorts add to the evidence that thiazide diuretics and ß-blockers can cause glucose intolerance.

Association of Diabetes and Hypertension with Shock-Wave Lithotripsy

Trauma to the kidneys and pancreas may explain the finding of a long-term risk.

Can Treating Hypertension Lower the Risk for Dementia?

Long-term BP-lowering treatment was associated with reduced risk for dementia in an observational study of Japanese American men.

ACE Inhibitors for Stable CAD Without LVSD: A Meta-Analysis

Findings should lessen concerns raised by the PEACE trial.

Antihypertensive Drugs and Development of Diabetes in Blacks

Ramipril was associated with significantly lower risk for diabetes than was metoprolol or amlodipine.

Items 151-175 of 195 are shown

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?





Copyright © 2009. Massachusetts Medical Society. All rights reserved.